-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/comments/hmv-disposition-of-comments.pdf
March 14, 2019 - Besides, N3 sleep stage duration decreased (2.5%
(IQR 0.0–18.0) vs 0.0% (IQR0.0–12.1), P= 0.001) and
-
www.ahrq.gov/sites/default/files/wysiwyg/healthsystemsresearch/decarbonization/decarbonization.pdf
September 01, 2022 - Reducing Healthcare Carbon Emissions: A Primer on Measures and Actions to Mitigate Climate Change
Reducing Healthcare
Carbon Emissions
A Primer on Measures and Actions for Healthcare
Organizations to Mitigate Climate Change
AH…
-
www.ahrq.gov/sites/default/files/wysiwyg/funding/training-grants/eric-roberts-draft-application.pdf
May 19, 2021 - Animals: N
Humans: Y
Clinical Trial: N
Current HS Code: 30
HESC: N
New Investigator:
Early Stage
-
www.ahrq.gov/sites/default/files/wysiwyg/cpi/about/organization/nac/snac-executive-summary.pdf
October 19, 2021 - The CAHPS program is
currently in its fifth stage, referred to as CAHPS V, which continues the work
-
www.ahrq.gov/sites/default/files/2024-07/bates3-report.pdf
January 01, 2024 - Final Progress Report: Making Acute Care More Patient Centered, Patient Safety Learning Laboratory (PSLL)
Title: Making Acute Care More Patient Centered, Patient Safety Learning Laboratory (PSLL)
Principal Investigator: David W. Bates, MD, MsC
Team Members: David Bates, MD, MsC, James Benneyan, PhD, Patricia Dykes,…
-
www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
January 01, 2024 - Final progress Report: Anticholinergics and Cognitive Decline in the Elderly with Depression
FINAL PROGRESS REPORT
ANTICHOLINERGICS AND COGNITIVE DECLINE IN THE ELDERLY WITH DEPRESSION
TITLE: Anticholinergics and Cognitive Decline in the Elderly with Depression
PRINICIPAL INVESTIGATOR: Aparasu, Rajender R.1
TEAM…
-
www.ahrq.gov/sites/default/files/publications/files/prioritization-report_0.pdf
January 01, 2020 - Use of gene expression profiling and chemotherapy in early-stage
breast cancer: a study of linked electronic
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/20150917/introducing_the_new_cahps_c&g_survey3.0.pdf
September 01, 2015 - Introducing the New CAHPS Clinician & Group Survey 3.0
Introducing the New CAHPS Clinician & Group Survey 3.0
September 2015 Webcast
Speakers
Julie Brown, Senior Study Director and Director, RAND Survey Research Group, Santa Monica, CA
Lee Hargraves, PhD, Managing Researcher, American Institutes for Resear…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/sppc-summary_report.pdf
May 01, 2017 - percent of patients with vaginal delivery
who were administered a uterotonic agent during the third stage
-
www.ahrq.gov/sites/default/files/2024-01/gallagher2-report.pdf
January 01, 2024 - Final Progress Report: Using Team Simulation to Improve Error Disclosure to Patients and Safety Culture
AHRQ Grant Final Progress Report
Title of Project: Using Team Simulation to Improve Error Disclosure to Patients and Safety
Culture
Principal Investigator: Thomas H. Gallagher, MD
Co-Investigators: Sarah Shann…
-
www.ahrq.gov/sites/default/files/2024-07/oconnor-report.pdf
January 01, 2024 - Final Progress Report: MOVES: Patient-Based Strategy To Reduce Errors in Diabetes Care
O’Connor, Patrick J.
Final Report
MOVES: Patient-Based Strategy to Reduce Errors in Diabetes Care
Patrick J. O’Connor MD MPH, Principal Investigator
Research Team Members: JoAnn Sperl-Hillen MD, Paul E. Johnson PhD†, William A. …
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/Medical-Office-Users-Guide-2021.pdf
January 01, 2021 - This chapter is designed to guide you through the planning
and decisionmaking stage of your project.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible
1
Continuity of Insurance: Coverage Presumed
Ineligible
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Coverage Presumed Ineligible
1.B. Measure Number
0155
1.C. Measure Description
Please provide a non-technical d…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment
1
Continuity of Insurance: Duration of First Observed
Enrollment
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Duration of First Observed Enrollment
1.B. Measure Number
0156
1.C. Measure Description
Please …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-fullreport.pdf
May 23, 2018 - Continuity of Insurance: Informed Participation
1
Continuity of Insurance: Informed Participation
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Informed Participation
1.B. Measure Number
0153
1.C. Measure Description
Please provide a non-technical description of the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-Compendium-TechDoc-update.pdf
January 01, 2018 - Model Name Type Scope
Medicare Shared Savings Program Accountable care National
Comprehensive End-Stage … with a health system that
participated in a Medicare Shared Savings Program ACO, a
Comprehensive End-Stage
-
www.ahrq.gov/downloads/pub/prevent/pdfser/chdser.pdf
December 08, 2003 - patients (59%) reported being more motivated to quit smoking after the scan but
neither motivation nor stage
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/chsp-tin-linkage-file-tech-doc.pdf
October 01, 2019 - Thus, the file is at the TIN-hospital CCN level at this
stage.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/nursing-home/nhguide/nhguide.pdf
August 01, 2016 - This chapter is designed to guide you through the
planning and decisionmaking stage of your project.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/comments/bariatric-disposition-comments.pdf
March 13, 2018 - patients if these
individuals were eligible for Medicare
benefits (e.g. disabled, patients with
end-stage